<i>ERJ</i> Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

<title>Extract</title> As part of the May issue, the <italic>European Respiratory Journal</italic> presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of the PULSAR and STELLAR studies.

Publication Details

Journal: European Respiratory Journal
Published: 2025-05-01
DOI: https://doi.org/10.1183/13993003.e6505-2025
Primary Topic: TGF-β signaling in diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

May 1, 2025

European Respiratory Journal

TGF-β signaling in diseases

article

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

May 1, 2025article en

Abstract

European Respiratory JournalVol. 65(5)

Openalex Percentile: Top 89%

TGF-β signaling in diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<i>ERJ</i> Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept · European Respiratory Journal (2025) | TGRS Research Map | TGRS